Baotou Dongbao Bio-Tech Co Ltd (SHE:300239) — Stock Price
Baotou Dongbao Bio-Tech Co Ltd (SHE:300239) is currently trading at CN¥5.10 CNY, up 3.03% today. Over the past 52 weeks, shares have ranged between CN¥4.52 and CN¥6.63. This page tracks Baotou Dongbao Bio-Tech Co Ltd's live share price on the SHE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see how much is Baotou Dongbao Bio-Tech Co Ltd worth.
Baotou Dongbao Bio-Tech Co Ltd (300239) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Baotou Dongbao Bio-Tech Co Ltd's daily closing share price and trading volume on the SHE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Baotou Dongbao Bio-Tech Co Ltd Income Statement — Revenue, Profit & Earnings by Year
Baotou Dongbao Bio-Tech Co Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | CN¥745.31 Million | CN¥884.93 Million | CN¥974.51 Million | CN¥943.40 Million | CN¥612.17 Million |
| Cost of Revenue | CN¥571.24 Million | CN¥687.88 Million | CN¥728.53 Million | CN¥712.28 Million | CN¥515.98 Million |
| Gross Profit | CN¥174.07 Million | CN¥197.06 Million | CN¥245.98 Million | CN¥231.12 Million | CN¥96.19 Million |
| Research & Development | CN¥25.48 Million | CN¥26.99 Million | CN¥24.66 Million | CN¥36.74 Million | CN¥19.28 Million |
| SG&A | CN¥17.64 Million | CN¥49.26 Million | CN¥50.14 Million | CN¥49.89 Million | CN¥29.53 Million |
| Total Operating Expenses | CN¥665.39 Million | CN¥90.87 Million | CN¥102.10 Million | CN¥100.60 Million | CN¥54.49 Million |
| Operating Income | CN¥79.92 Million | CN¥106.18 Million | CN¥143.88 Million | CN¥130.51 Million | CN¥41.69 Million |
| EBITDA | — | CN¥194.71 Million | CN¥231.83 Million | CN¥224.90 Million | CN¥101.73 Million |
| EBIT | — | CN¥108.39 Million | CN¥149.87 Million | CN¥139.38 Million | CN¥46.41 Million |
| Interest Expense | CN¥4.01 Million | CN¥2.75 Million | CN¥5.37 Million | CN¥7.74 Million | CN¥4.87 Million |
| Income Before Tax | CN¥61.92 Million | CN¥105.63 Million | CN¥144.49 Million | CN¥131.65 Million | CN¥41.54 Million |
| Income Tax Expense | — | CN¥14.37 Million | CN¥17.12 Million | CN¥16.21 Million | CN¥5.72 Million |
| Net Income | CN¥54.34 Million | CN¥85.98 Million | CN¥119.89 Million | CN¥109.44 Million | CN¥36.48 Million |
Baotou Dongbao Bio-Tech Co Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Baotou Dongbao Bio-Tech Co Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | CN¥2.55 Billion | CN¥2.62 Billion | CN¥2.74 Billion | CN¥2.31 Billion | CN¥2.11 Billion |
| Total Current Assets | CN¥1.15 Billion | CN¥1.23 Billion | CN¥1.35 Billion | CN¥1.02 Billion | CN¥892.59 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | CN¥180.62 Million | CN¥335.10 Million | CN¥304.38 Million | CN¥335.79 Million | CN¥302.47 Million |
| Inventory | CN¥401.37 Million | CN¥354.46 Million | CN¥281.53 Million | CN¥317.84 Million | CN¥346.02 Million |
| Property, Plant & Equipment | — | — | — | CN¥1.02 Billion | CN¥966.90 Million |
| Goodwill | — | — | — | — | — |
| Total Liabilities | CN¥826.49 Million | CN¥885.50 Million | CN¥848.82 Million | CN¥552.26 Million | CN¥508.58 Million |
| Total Current Liabilities | CN¥235.85 Million | CN¥323.77 Million | CN¥300.94 Million | CN¥316.26 Million | CN¥421.39 Million |
| Long-term Debt | CN¥493.70 Million | CN¥471.90 Million | CN¥462.82 Million | CN¥152.00 Million | — |
| Net Debt | CN¥11.32 Million | CN¥108.44 Million | CN¥-279.41 Million | CN¥-161.02 Million | CN¥-175.35 Million |
| Total Stockholder Equity | CN¥1.72 Billion | CN¥1.74 Billion | CN¥1.66 Billion | CN¥1.53 Billion | CN¥1.42 Billion |
| Retained Earnings | CN¥448.91 Million | CN¥411.41 Million | CN¥344.81 Million | CN¥251.52 Million | CN¥156.10 Million |
Baotou Dongbao Bio-Tech Co Ltd Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Baotou Dongbao Bio-Tech Co Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | CN¥105.92 Million | CN¥69.13 Million | CN¥199.39 Million | CN¥195.32 Million | CN¥51.50 Million |
| Capital Expenditures | CN¥79.27 Million | CN¥77.17 Million | CN¥132.24 Million | CN¥108.56 Million | CN¥51.35 Million |
| Free Cash Flow | CN¥26.65 Million | CN¥-8.04 Million | CN¥67.15 Million | CN¥86.76 Million | CN¥149.96K |
| Investing Cash Flow | — | CN¥-266.05 Million | CN¥-130.41 Million | CN¥-224.17 Million | CN¥-168.44 Million |
| Financing Cash Flow | — | CN¥-18.42 Million | CN¥305.87 Million | CN¥175.08 Million | CN¥261.04 Million |
| Dividends Paid | CN¥18.28 Million | CN¥15.81 Million | CN¥21.28 Million | CN¥3.56 Million | CN¥5.73 Million |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | CN¥97.26 Million | CN¥86.44 Million | CN¥81.96 Million | CN¥85.52 Million | CN¥55.32 Million |
| Change in Cash | CN¥-39.34 Million | CN¥-215.34 Million | CN¥374.99 Million | CN¥146.58 Million | CN¥144.08 Million |
Baotou Dongbao Bio-Tech Co Ltd Earnings History — EPS Actual vs. Analyst Estimates
Track Baotou Dongbao Bio-Tech Co Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Mar 31, 2026 | 0.03 | — | — |
| Dec 31, 2025 | 0.01 | — | — |
| Sep 30, 2025 | 0.02 | — | — |
| Jun 30, 2025 | 0.03 | — | — |
| May 14, 2025 | 0.03 | — | — |
| Dec 31, 2024 | 0.03 | — | — |
| Sep 30, 2024 | 0.02 | — | — |
| Jun 30, 2024 | 0.04 | — | — |